FLC
MACK

Fifth Lane Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Fifth Lane Capital’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,929
Closed -$134K – 225
2023
Q3 		$134K Hold
10,929
– – 0.05% 58
2023
Q2 		$134K Buy
+10,929
New +$134K 0.04% 54